United States Cancer Treatment Drugs Market Research Report Forecast 2017 to 2022

December 2017 | 127 pages | ID: U13CF640BD3EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Cancer Treatment Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Cancer Treatment Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Treatment Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Roche
Novartis
Celgene
Amgen
Johnson & Johnson
Bristol-Myers Squibb
Takeda
Eli Lilly
Pfizer

United States Cancer Treatment Drugs Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Cancer Treatment Drugs Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 CANCER TREATMENT DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Cancer Treatment Drugs Market Segmentation by Type
  1.2.1 United States Production Market Share of Cancer Treatment Drugs by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Cancer Treatment Drugs Market Segmentation by Application
  1.3.1 Cancer Treatment Drugs Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Treatment Drugs (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON CANCER TREATMENT DRUGS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES CANCER TREATMENT DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Cancer Treatment Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Cancer Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Cancer Treatment Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Treatment Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Treatment Drugs Market Competitive Situation and Trends
  3.5.1 Cancer Treatment Drugs Market Concentration Rate
  3.5.2 Cancer Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES CANCER TREATMENT DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Cancer Treatment Drugs Production and Market Share by Type (2012-2017)
4.2 United States Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Treatment Drugs Price by Type (2012-2017)
4.4 United States Cancer Treatment Drugs Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES CANCER TREATMENT DRUGS MARKET ANALYSIS BY APPLICATION

5.1 United States Cancer Treatment Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Cancer Treatment Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES CANCER TREATMENT DRUGS MANUFACTURERS ANALYSIS

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Novartis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Celgene
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Amgen
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Johnson & Johnson
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Bristol-Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Takeda
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Eli Lilly
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Pfizer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 CANCER TREATMENT DRUGS MANUFACTURING COST ANALYSIS

7.1 Cancer Treatment Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Treatment Drugs

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Treatment Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES CANCER TREATMENT DRUGS MARKET FORECAST (2017-2022)

11.1 United States Cancer Treatment Drugs Production, Revenue Forecast (2017-2022)
11.2 United States Cancer Treatment Drugs Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Cancer Treatment Drugs Production Forecast by Type (2017-2022)
11.4 United States Cancer Treatment Drugs Consumption Forecast by Application (2017-2022)
11.5 Cancer Treatment Drugs Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGUES

Figure Picture of Cancer Treatment Drugs
Table Classification of Cancer Treatment Drugs
Figure United States Sales Market Share of Cancer Treatment Drugs by Type in 2016
Table Application of Cancer Treatment Drugs
Figure United States Sales Market Share of Cancer Treatment Drugs by Application in 2016
Figure United States Cancer Treatment Drugs Sales and Growth Rate (2011-2021)
Figure United States Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Table United States Cancer Treatment Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Treatment Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Treatment Drugs Sales Share by Manufacturers
Figure 2016 Cancer Treatment Drugs Sales Share by Manufacturers
Table United States Cancer Treatment Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Treatment Drugs Revenue Share by Manufacturers
Table 2016 United States Cancer Treatment Drugs Revenue Share by Manufacturers
Table United States Market Cancer Treatment Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Treatment Drugs Average Price of Key Manufacturers in 2015
Figure Cancer Treatment Drugs Market Share of Top 3 Manufacturers
Figure Cancer Treatment Drugs Market Share of Top 5 Manufacturers
Table United States Cancer Treatment Drugs Sales by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales Share by Type (2012-2017)
Figure United States Cancer Treatment Drugs Sales Market Share by Type in 2015
Table United States Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
Table United States Cancer Treatment Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Treatment Drugs by Type (2012-2017)
Table United States Cancer Treatment Drugs Price by Type (2012-2017)
Figure United States Cancer Treatment Drugs Sales Growth Rate by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales by Application (2012-2017)
Table United States Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Figure United States Cancer Treatment Drugs Sales Market Share by Application in 2016
Table United States Cancer Treatment Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Treatment Drugs Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Cancer Treatment Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Treatment Drugs Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgene Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Cancer Treatment Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Treatment Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Cancer Treatment Drugs Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Treatment Drugs Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Takeda Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Cancer Treatment Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Cancer Treatment Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Cancer Treatment Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders List
Figure United States Cancer Treatment Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Cancer Treatment Drugs Production Forecast by Type (2017-2022)
Table United States Cancer Treatment Drugs Consumption Forecast by Application (2017-2022)